Karmanos Cancer Institute/Wayne State University School of Medicine — Detroit, Michigan

Karmanos Cancer Institute/Wayne State University School of Medicine is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute/Wayne State University School of Medicine has participated in 1 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic.

Sponsors: Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Detroit

Browse all research sites in Michigan · View every site in Detroit

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute/Wayne State University School of Medicine?

Karmanos Cancer Institute/Wayne State University School of Medicine has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute/Wayne State University School of Medicine conducted?

Karmanos Cancer Institute/Wayne State University School of Medicine has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic.

Is Karmanos Cancer Institute/Wayne State University School of Medicine accredited by Crixeo Clinical Trials?

Karmanos Cancer Institute/Wayne State University School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute/Wayne State University School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.